Tumour Necrosis Factor Superfamily Members in the Pathogenesis of Inflammatory Bowel Disease

Tumour Necrosis Factor Superfamily Members in the Pathogenesis of Inflammatory Bowel Disease

Bibliographic Details
Main Authors:	Tomasz J. Ślebioda, Zbigniew Kmieć
Format:	Article
Language:	English
Published:	Hindawi Limited 2014-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2014/325129

Similar Items

Regulation of neurite growth by tumour necrosis superfamily member RANKL
by: Humberto Gutierrez, et al.
Published: (2013-01-01)

A study of the structure and function of tumour necrosis factor receptor superfamily members
by: Kimberley, Fiona
Published: (2004)

Tumour necrosis factor receptor superfamily members in chicken B cell development
by: Kamu Reddy, Shalini
Published: (2008)

Homology modelling and analysis of structure predictions of human tumour necrosis factor ligand superfamily member 8
by: Babatunde Joseph Oso, et al.
Published: (2021-06-01)

Tumor Necrosis Factor Receptor Superfamily, Member 1B Haplotypes Increase or Decrease the Risk of Inflammatory Bowel Diseases in a New Zealand Caucasian Population
by: Lynnette R. Ferguson, et al.
Published: (2009-01-01)

Cell death, stomach pain and migratory rashes : structure-functional analysis of tumour necrosis factor receptor superfamily members in health and disease
by: Lobito, Adrian A.
Published: (2006)

Tumour necrosis factor receptor superfamily memebers in chicken B cell development
by: Reddy, Shalini Kamu
Published: (2008)

Differential Roles of Tumor Necrosis Factor Ligand Superfamily Members as Biomarkers in Pancreatic Cancer
by: Ines Pombeiro, et al.
Published: (2018-07-01)

Immunological pathogenesis of inflammatory bowel disease
by: Seung Hoon Lee, et al.
Published: (2018-01-01)

Overview of Inflammatory Bowel Disease Pathogenesis
by: C Fiocchi
Published: (1990-01-01)

The Role of TNF-α and TNF Superfamily Members in the Pathogenesis of Calcific Aortic Valvular Disease
by: Antonella Galeone, et al.
Published: (2013-01-01)

The Tumor Necrosis Factor Superfamily of Cytokines in the Inflammatory Myopathies: Potential Targets for Therapy
by: Boel De Paepe, et al.
Published: (2012-01-01)

Transforming growth factor-beta superfamily members in the pathogenesis of pulmonary arterial hypertension
by: Jerkić Mirjana
Published: (2012-01-01)

Editorial: Ying and Yang Members of the Tumor Necrosis Factor Superfamily: Friends or Foes in Immune-Mediated Diseases and Cancer
by: Adebola Giwa, et al.
Published: (2017-11-01)

Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease
by: Al Sulais E, et al.
Published: (2020-01-01)

Antitumor necrosis factor treatment for pediatric inflammatory bowel disease
by: Darja Urlep, et al.
Published: (2013-10-01)

Anti-tumor necrosis factor therapy in inflammatory bowel disease
by: B S Ramakrishna
Published: (2017-01-01)

The Role of Macrophages in the Pathogenesis of Inflammatory Bowel Disease
by: YR Mahida
Published: (1993-01-01)

New Concepts of Pathogenesis in Inflammatory Bowel Disease
by: Claudio Fiocchi
Published: (1995-01-01)

Inflammatory Bowel Disease: Genetics, Epigenetics and Pathogenesis
by: Italia eLoddo, et al.
Published: (2015-11-01)

Dysbiosis in the Pathogenesis of Pediatric Inflammatory Bowel Diseases
by: Donatella Comito, et al.
Published: (2012-01-01)

Aspects of the Pathogenesis and Management of Inflammatory Bowel Diseases
by: Andrew S. Day
Published: (2021-07-01)

Anti-tumor Necrosis Factor Agents and Tuberculosis in Inflammatory Bowel Disease
by: Yunho Jung
Published: (2020-01-01)

Novel Insights on the Regulation of B Cell Functionality by Members of the Tumor Necrosis Factor Superfamily in Jawed Fish
by: Carolina Tafalla, et al.
Published: (2018-06-01)

Genetic factors in pathogenesis, course and treatment of inflammatory bowel diseases
by: Hubert Zatorski, et al.
Published: (2015-03-01)

The microbiome in inflammatory bowel diseases: from pathogenesis to therapy
by: Sheng Liu, et al.
Published: (2020-06-01)

The role of the Hippo pathway in the pathogenesis of inflammatory bowel disease
by: Zhuo Xie, et al.
Published: (2021-01-01)

Nuclear Receptors in the Pathogenesis and Management of Inflammatory Bowel Disease
by: Longgui Ning, et al.
Published: (2019-01-01)

The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
by: Tao Zuo, et al.
Published: (2018-09-01)

Inflammatory Bowel Disease: Autoimmune or Immune-mediated Pathogenesis?
by: Zhonghui Wen, et al.
Published: (2004-01-01)

Review: Local Tumor Necrosis Factor-α Inhibition in Inflammatory Bowel Disease
by: Bahez Gareb, et al.
Published: (2020-06-01)

Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial
by: María Chaparro, et al.
Published: (2019-09-01)

Lymphocyte signalling through members of the Tumour Necrosis Factor Receptor family
by: Wood, Katrina Mackay
Published: (1996)

Risk factors for tuberculosis in inflammatory bowel disease: anti-tumor necrosis factor and hospitalization
by: Sabino Riestra, et al.

Reverse Signaling of Tumor Necrosis Factor Superfamily Proteins in Macrophages and Microglia: Superfamily Portrait in the Neuroimmune Interface
by: Won-Ha Lee, et al.
Published: (2019-02-01)

Functional characterisation of tumour necrosis factor receptor superfamily 1A (TNFRSF1A) mutations that cause systemic inflammation
by: Siebert, Stefan
Published: (2005)

TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases
by: Juliane Totzke, et al.
Published: (2020-09-01)

Association of Tumor Necrosis Factor Alpha Gene Polymorphisms with Inflammatory Bowel Disease in Iran.
by: Nosratollah Naderi, et al.
Published: (2014-05-01)

Predicting durable response or resistance to antitumor necrosis factor therapy in inflammatory bowel disease
by: Uri Kopylov, et al.
Published: (2016-07-01)

Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor
by: Cristiano Pagnini, et al.
Published: (2019-06-01)